Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers (CASINO)

NCT05662865 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.

NCT NCT05662865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05662865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers (CASINO)
Lead sponsor
AdventHealth Translational Research Institute
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 16, 2023
Completion date
December 31, 2026
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ketones, metabolism